Concepedia

Alfred T. Harding

AT

11

Publications

623

Citations

10

H-Index

2017

Active since

Affiliations

Duke University(Current)

Icahn School of Medicine at Mount Sinai

Harvard University

University of Bristol

Cell Signaling Technology (United States)

Alfred T. Harding is an author at Duke University specializing in cell signaling, viral pathogenesis, and virology.

ORCID

Top concepts

Publications per year

2017–2022

11

Publications

11

A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor

Brook E. Heaton, Edward M. Kennedy, Rebekah E. Dumm et al. · Cell Reports · 2017 · 142 citations · Full text

Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication

Tomer M. Yaron, Brook E. Heaton, Tyler Levy et al. · Science Signaling · 2022 · 89 citations · Full text

, , +14

Control of antiviral innate immune response by protein geranylgeranylation

Shigao Yang, Alfred T. Harding, Catherine Sweeney et al. · Science Advances · 2019 · 65 citations · Full text

The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro

Tomer M. Yaron, Brook E. Heaton, Tyler Levy et al. · 2020 · 63 citations · Full text

GPER1 is required to protect fetal health from maternal inflammation

Alfred T. Harding, Marisa Goff, Heather M. Froggatt et al. · Science · 2021 · 61 citations · Full text

Rows per page

1–5 of 11